Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease.

Several reports have linked the presence of certain serum autoantibodies with particular clinical manifestations of autoimmune disease. For example, the Jo-1 antibody is now established as a marker for fibrosing alveolitis in polymyositis. To investigate the possible association of further autoantibodies or idiotypes with fibrosing alveolitis in autoimmune rheumatic disease a panel of autoantibodies was measured in serum samples from 28 patients with systemic lupus erythematosus (SLE) (10 with and 18 without lung involvement), 21 patients with scleroderma (12 with fibrosing alveolitis and nine without), and 41 patients with 'lone' fibrosing alveolitis. Antibodies measured were IgM and IgG anti-dsDNA and anti-ssDNA antibody; IgG and IgM anticardiolipin antibody; anti-poly (ADP-ribose) antibody; antibodies to two common idiotypes of anti-DNA antibodies, designated 134 and 16/6; and IgM, IgG, and IgA isotypes of rheumatoid factor. None of these antibodies was specifically associated with lung involvement in SLE or scleroderma, but a trend was found towards an increase in all autoantibodies in association with lung disease in SLE, while the reverse trend was seen in scleroderma.
AuthorsL Turner-Stokes, P Haslam, M Jones, C Dudeney, S Le Page, D Isenberg
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 49 Issue 3 Pg. 160-2 (Mar 1990) ISSN: 0003-4967 [Print] ENGLAND
PMID2322027 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Autoantibodies
  • Immunoglobulin Idiotypes
  • Rheumatoid Factor
  • Antibodies, Antinuclear (analysis)
  • Autoantibodies (analysis)
  • Autoimmune Diseases (immunology)
  • Humans
  • Immunoglobulin Idiotypes (analysis)
  • Lung (immunology)
  • Lupus Erythematosus, Systemic (immunology)
  • Pulmonary Fibrosis (immunology)
  • Rheumatoid Factor (analysis)
  • Scleroderma, Systemic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: